Serum Concentration of Bevacizumab after Intravitreal Injection in Experimental Branch Retinal Vein Occlusion

Publisher： Karger

E-ISSN： 1423-0259|45|1|31-35

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.45, Iss.1, 2010-08, pp. : 31-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Bevacizumab and Cytokine Levels in Major and Macular Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 225, Iss. 3, 2010-12 ,pp. : 150-154

Karger

Access to resources Recommend Favorite

Early Intravitreal Bevacizumab for Non-Ischaemic Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 223, Iss. 2, 2008-12 ,pp. : 124-127

Karger

Access to resources Recommend Favorite

Changes in the Retinal Vascular Network Morphology (Diameter and Tortuosity) after Administration of Intravitreal Bevacizumab in a Patient with Ischaemic Branch Retinal Vein Occlusion

By  

Case Reports in Ophthalmology, Vol. 5, Iss. 3, 2014-12 ,pp. : 411-415

Karger

Access to resources Recommend Favorite

Intravitreal Bevacizumab Treatment for Macular Edema due to Branch Retinal Vein Occlusion in a Clinical Setting

By Siegel Ruth Axer   Dreznik Ayelet   Mimouni Karin   Bor Elite   Weinberger Dov   Bourla Dan Haim  

Current Eye Research, Vol. 37, Iss. 9, 2012-09 ,pp. : 823-829

Informa Healthcare

Access to resources Recommend Favorite

Prospective Pilot Study: Efficacy of Intravitreal Dexamethasone and Bevacizumab Injections in the Treatment of Macular Oedema Associated with Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 230, Iss. 1, 2013-05 ,pp. : 43-49

Karger

Access to resources Recommend Favorite